Perioperative immunomodulation with interleukin-2 in patients with renal cell carcinoma: results of a controlled phase II trial

por Klatte, T, Ittenson, A, Röhl, F-W, Ecke, M, Allhoff, E P, Böhm, M
Publicado 2006

Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: Results of a prospectively randomised Trial...

por Atzpodien, J, Schmitt, E, Gertenbach, U, Fornara, P, Heynemann, H, Maskow, A, Ecke, M, Wöltjen, H H, Jentsch, H, Wieland, W, Wandert, T, Reitz, M
Publicado 2005